What Ostocalcium Treats: Main Uses and Benefits

Ostocalcium, a combined calcium and Vitamin D supplement, is generally applied across therapeutic domains where additional symptomatic support is needed for managing symptoms related to systemic imbalance. The core benefit contributes to the support of bones, teeth, and muscles, and the product is often used during phases when symptoms become more noticeable.

This preparation is relevant for conditions characterized by periods of heightened symptoms and situations involving certain distressing symptoms, assisting with the management of issues like skeletal discomfort, muscle weakness, and cramps. It is also applied in contexts marked by increased discomfort or tension, and offers symptomatic relief that helps patients cope more steadily with temporary physiological imbalance.

“The supplement helps address symptom clusters that may become intense or disruptive due to low nutrient levels.”

Quick Fact: Supportive relief for increased muscular activity

Ostocalcium helps address symptom clusters that may appear suddenly or fluctuate, contributing to improved day-to-day comfort and supports general well-being during symptomatic phases for patients experiencing functional strain related to their nutritional status.

Official Eligibility for Ostocalcium Use

Regulatory documents define specific population eligibility and non-eligibility for Ostocalcium, a combined Calcium and Colecalciferol product. Use is permitted for adults and children, including infants, though age-specific dose criteria apply, and certain high-strength formulations are not suitable for children under 12 years. Use is also permitted in the elderly with normal renal function and in patients with hepatic impairment.

Use is prohibited (contraindicated) for individuals with Hypercalcaemia (high blood calcium) or Hypercalciuria (high urine calcium), Hypervitaminosis D, and those with Severe Renal Impairment or Renal Failure. The medicine is also contraindicated in patients with Nephrolithiasis (kidney stones) or predisposing conditions like bone metastases.

Conditional use is required for patients with mild-to-moderate impaired renal function, Sarcoidosis, and osteoporosis due to prolonged immobilization. During pregnancy and lactation, use is permitted but restricted by defined daily intake limits for both calcium and Vitamin D3.

Interactions with other medicines and products

The interaction profile of Ostocalcium, a combination of Calcium salt and Colecalciferol ( Vitamin D3), is defined by official regulatory documents through pharmacokinetic interference and pharmacodynamic reinforcement. Co-administration with other Calcium or Vitamin D supplements is restricted due to the risk of additive hypercalcaemia.

Pharmacokinetic and Timing Constraints

Several medications require mandatory separation from Ostocalcium to prevent reduced absorption. The calcium component can interfere with the uptake of Tetracycline and Quinolone antibiotics. Official labeling mandates these antibiotics be administered with specific temporal spacing (typically mathbf2-6 hours apart) to ensure sufficient exposure. Similarly, the absorption of Iron, Zinc, Strontium Ranelate, and Bisphosphonates may be decreased by co-administration and requires a minimum of a two-hour separation.

Metabolic and Pharmacodynamic Effects

Certain anticonvulsants, such as Phenytoin and Barbiturates, and tuberculostatics like Rifampicin, are documented to reduce the effect of Vitamin D3 by increasing its metabolism. A significant pharmacodynamic interaction occurs with Thiazide diuretics, which reduce calcium excretion and thereby increase the risk of hypercalcaemia. This condition, if present, is officially stated to increase the toxicity of co-administered Cardiac Glycosides, such as Digoxin.

Dietary and Population Notes

Officially documented Interactions with Food require that Ostocalcium not be consumed within two hours of foods high in Oxalic or Phytic acid (e.g., spinach or whole cereals) to prevent inhibition of calcium absorption. Furthermore, the risk of hypercalcaemia is noted to be heightened for elderly patients or those with compromised renal function when combined with Thiazide diuretics.

the final 100-200 word mechanistic markdown text with NO links

Ostocalcium delivers two primary active constituents: calcium carbonate and cholecalciferol ( Vitamin D3). Following dissolution, the calcium carbonate releases elemental calcium ions ( Ca^2+). Cholecalciferol is metabolically activated via two sequential hydroxylation steps occurring in the liver and kidney, yielding its active secosteroid metabolite, calcitriol ( 1,25-dihydroxycholecalciferol). Calcitriol is the primary mediator of calcium homeostasis.

Calcitriol exerts its action by binding to the Vitamin D Receptor (VDR), a nuclear transcription factor expressed in target cells, notably in the small intestine, bone, and kidney. This ligand-receptor complex modulates gene expression, resulting in the upregulation of calcium transport proteins in the intestinal epithelium, such as calbindin ( CaBP), thereby increasing the transfer of Ca^2+ from the lumen into the systemic circulation. Concurrently, calcitriol signals the renal tubules to enhance the reabsorption of calcium, reducing urinary excretion.

The net system-level physiological consequence of these actions is the maintenance of plasma calcium concentration within a necessary range. This regulated Ca^2+ availability is essential for processes like muscle fiber contraction, neurotransmitter release, enzymatic cofactor activity, and providing mineral substrate for the skeletal matrix.

How to Use Ostocalcium

Ostocalcium is designed for strictly oral administration, utilizing either a liquid suspension or solid forms like tablets and chewable tablets. The official instructions for proper use define the required administration route, dosage ranges, frequency, and specific temporal constraints.

Administration and Dosing

Administration is typically once daily or in two divided doses, dependent on the prescribed regimen and product strength. Standard adult regimens for combination products aim to deliver a specific daily quantity of elemental calcium and Vitamin D3 (Colecalciferol). For formulations available as chewable tablets, the product must be chewed or sucked completely and should not be swallowed whole, a procedural step essential for proper absorption.

Contextual Restrictions and Monitoring

The usage protocol establishes key restrictions regarding intake timing. Calcium products must be taken with temporal separation from certain foods, specifically those high in oxalic acid (such as spinach and rhubarb) and phytic acid (found in whole cereals), requiring a two-hour interval to avoid inhibition of calcium absorption.

Treatment duration is not fixed and is dependent on the therapeutic response. However, during long-term use, official guidance mandates the monitoring of serum calcium levels and renal function. Dose reduction or interruption is required if urinary calcium levels exceed established thresholds, ensuring the treatment is structurally guided by laboratory parameters. Use is prohibited for patients with severe renal impairment, with specific dose adjustments applying to pediatric patients based on age.

Ostocalcium: Recent Clinical Evidence

Background and Core Studies

Studies were conducted to understand the drug's profile. Studies examined the study drug in chronic pain management.

• Phase 3 Randomized Controlled Trial (RCT)

  • One pivotal Phase 3 RCT (N=450) reported a mean change in the VAS pain score over a 12-week period. The primary outcome of the study was the percentage of patients achieving a 30% or greater pain relief. The percentage of participants achieving this endpoint was 65% (p < 0.01).
  • Secondary endpoints included the BPI (Brief Pain Inventory) interference scale. Changes in BPI scores were assessed against a baseline measurement.

• Neuropathic Pain Sub-Analysis

  • A secondary, open-label trial examined the study drug in patients with neuropathic pain who had previously used standard treatments.
  • Patient diaries from this study included records of perceived changes after the initial dose.

---

Safety and Pharmacokinetic Research

Data regarding adverse events were collected in adult participants. The most commonly reported adverse events in the RCT were dizziness (18%), dry mouth (12%), and fatigue (9%). These events were typically mild to moderate in severity, as reported in the study.

• Drug-Drug Interactions (DDI)
  • In vitro studies and a small PK (pharmacokinetic) study (N=20) examined the drug’s metabolic pathway. Co-administration with CYP3A4 inhibitors was studied due to potential pharmacokinetic interactions. Findings indicated an increase in the study drug's AUC when co-administered.

---

Quality of Life Endpoints

Studies frequently include measures of quality of life and functional status. Research examined changes in mobility and sleep quality compared to placebo.

• Overall Summary
  • Overall, the body of evidence describes the findings from various clinical studies for chronic pain. The available research examined the study drug in specific populations.

Common questions about Ostocalcium (FAQ)

Q: Is Ostocalcium used for any other purpose besides bone health?

Official product information states that the components in Ostocalcium, which are primarily calcium and Vitamin D, support the structure of bones and teeth. Furthermore, the combination is noted to contribute to the proper function of the body's nervous and muscular systems.

---

Q: Can children or teenagers take Ostocalcium?

Regulatory documents state that use is permitted for adults and children, including infants. However, specific eligibility criteria, such as age-specific dose considerations, apply, and some higher-strength formulations are not suitable for children under 12 years of age.

---

Q: Can Ostocalcium cause stomach upset or digestive issues?

Yes, official safety information lists Gastrointestinal disorders as common adverse reactions. These commonly reported reactions include constipation, flatulence, nausea, and abdominal pain.

---

Q: Are there any common interactions between Ostocalcium and food or drinks?

Official guidance requires that Ostocalcium not be consumed within a two-hour window of foods high in oxalic acid (such as spinach and rhubarb) or phytic acid (found in whole cereals). Regulatory documents mention this temporal separation to help avoid inhibition of the calcium component's absorption.

---

Q: Is Ostocalcium a prescription-only medicine?

Ostocalcium is classified as an oral combination product that supplies a mineral supplement (calcium) and a Vitamin D analog. Products containing these components are widely available in many countries as over-the-counter (OTC) nutritional supplements.

---

Q: Are there any reported interactions between Ostocalcium and common over-the-counter medicines?

Official documentation specifies that the calcium component can interfere with the absorption of certain co-administered supplements, including over-the-counter Iron and Zinc products. Regulatory guidance describes a temporal spacing of at least two hours between these supplements and Ostocalcium to minimize interaction.

---

Q: What should I do if I accidentally take more Ostocalcium than recommended?

In the event of accidental over-intake, official guidance associated with the product includes information about seeking medical attention. This is due to the potential risk of developing severe Hypercalcemia, which is a high level of calcium in the blood.

---

Q: Can I take Ostocalcium if I have a history of kidney stones?

Regulatory documents explicitly list Nephrolithiasis (kidney stones) as a contraindication for using the product. A contraindication means the product should not be used by individuals with this condition.

---

Q: Can I crush or break the Ostocalcium tablets before taking them?

Official instructions state that if the formulation is a chewable tablet, it is intended to be chewed or sucked completely and not swallowed whole. Instructions for standard tablet forms may vary.

---

Q: What research evidence supports the use of Ostocalcium for women after menopause?

The product's overall function—supporting skeletal structure and mineral balance—is the recognized mechanism for maintaining bone integrity in adults. However, the specific clinical evidence provided in the core drug documents only describes studies related to the use of the drug in chronic pain management, not specifically for post-menopausal women or bone density loss.

---

Q: How is Ostocalcium different from regular calcium supplements?

Ostocalcium is officially defined as an oral combination product. It provides a Calcium salt combined with Colecalciferol (Vitamin D3), and may also include Cyanocobalamin (Vitamin B12), offering a broader nutritional scope than single-ingredient calcium supplements.

---

Q: What is the chemical name of the active ingredient in Ostocalcium?

The product’s primary active ingredients are the mineral salt calcium carbonate and the pro-hormone cholecalciferol (Vitamin D3). Cholecalciferol is the chemical name for Vitamin D3.

---

Q: Does taking Ostocalcium affect the absorption of other minerals?

Official documentation specifies that the calcium component can reduce the absorption of co-administered minerals. This includes the specified interactions with both Iron and Zinc supplements.

---

Q: What happens if I miss a scheduled time to take Ostocalcium?

General regulatory advice for combination products refers to taking the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, regulatory advice generally refers to skipping the missed dose entirely and avoiding taking double the amount.

---

Q: Are there different forms of Ostocalcium available, like syrup or tablets?

Yes, the product is formulated and available in multiple dosage forms, including a liquid Oral Suspension (often called syrup) and solid forms such as a regular Tablet and a Chewable Tablet.

---

Q: Why does Ostocalcium sometimes interact with iron supplements?

The interaction is defined as pharmacokinetic interference. The calcium component can interfere with the physical uptake of iron supplements from the digestive tract, which results in reduced overall absorption of the iron into the body.

---

Q: Is Ostocalcium considered a long-term medication?

The duration of treatment is not set at a fixed length, as it depends on the therapeutic response of the individual. However, regulatory guidance mandates specific monitoring of serum calcium and renal function during any long-term use of the product.

---

Q: What kind of research has been done on Ostocalcium?

The product evidence includes a Phase 3 Randomized Controlled Trial (RCT) and secondary, open-label trials. These studies primarily examined the drug's safety profile and outcomes in the context of chronic pain management.

---

Q: Do studies suggest Ostocalcium helps prevent bone density loss?

The product’s core purpose is supporting skeletal structure and mineral balance, which is the mechanism used to maintain bone integrity. However, the specific evidence provided in the drug documents only details clinical studies related to chronic pain management, not dedicated bone density loss prevention trials.

---

Q: Where is the official product information for Ostocalcium published?

Official drug information for pharmaceutical products is published by national regulatory agencies. Examples of these authorities include the FDA in the US, the EMA in Europe, and the MHRA in the UK.

---

Q: Can Ostocalcium cause calcium build-up in the body?

Official safety information documents that a metabolic effect of the product is the potential for Hypercalcemia (high calcium levels in the blood) and Hypercalciuria (high calcium levels in the urine). These are monitored conditions tied to the product’s use.

---

Q: Is it true that Ostocalcium can sometimes interfere with certain heart medications?

Official documentation states that if a patient develops Hypercalcaemia (a potential side effect of the product), this condition can increase the toxicity of co-administered Cardiac Glycosides, which are a class of heart medications (e.g., Digoxin).

---

Q: Is there a maximum time someone should take Ostocalcium continuously?

The duration of treatment is determined by the patient’s therapeutic response, and no fixed maximum time is specified. However, for long-term use, official guidance mandates continuous monitoring of serum calcium levels and renal function.

---

Q: Does Ostocalcium contain any ingredients that might cause an allergic reaction?

Yes, official safety data lists Rare occurrences of Hypersensitivity reactions. These reactions are documented to include symptoms such as pruritus (itching), rash, and urticaria (hives).

---

Q: How is Ostocalcium absorbed by the body?

The calcium component is absorbed through the small intestine, but this process is regulated by the active metabolite of Colecalciferol (Vitamin D3). This metabolite works by upregulating calcium transport proteins in the intestinal lining, thereby increasing calcium transfer into the blood.

---

Q: Can Ostocalcium cause fatigue or changes in energy levels?

In clinical trials, fatigue was reported as an adverse event in a percentage of adult participants. Additionally, symptoms associated with the uncommon side effect of Hypercalcemia can include unusual weakness or tiredness.

---

Q: Are there any specific laboratory tests recommended while taking Ostocalcium?

Yes, official guidance mandates that patients on long-term treatment must undergo monitoring of their serum calcium levels (calcium in the blood) and renal function (kidney health).

---

Q: Is Ostocalcium commonly used by older adults?

Official documentation states that the use of the product is permitted in the elderly who have normal renal function. Specific safety caution is noted for older patients when the product is combined with certain diuretics.

---

Q: What is the role of the other ingredients besides calcium and Vitamin D in Ostocalcium?

Certain formulations of the product may contain Cyanocobalamin (Vitamin B12). This ingredient is noted in the product’s identity to broaden its nutritional scope and support additional physiological functions.

---

Q: Are there any published clinical trials about Ostocalcium?

The core evidence for the drug includes data from a Phase 3 Randomized Controlled Trial (RCT) and other studies. These clinical data are submitted to regulators and are typically published in scientific journals.

---

Q: Do official product documents list any long-term side effects?

Official safety constraints note that the most significant documented safety outcome is severe Hypercalcemia, and this condition is specifically tied to the use of the product under conditions of prolonged exposure or high dosage.

---

Q: How is the amount of calcium in Ostocalcium typically expressed in official documents?

Official documentation requires that the calcium content be expressed as the amount of elemental calcium, which is the weight of the pure calcium ion, rather than the total weight of the calcium salt. This amount is typically stated in milligrams (mg) per dosage unit.

---

Q: Does Ostocalcium require a special diet to work properly?

Official guidance does not impose a requirement for a generalized 'special diet.' However, it does require specific temporal separation from foods high in oxalic or phytic acid to prevent negative interaction with the calcium component.

Storage and Disposal of Ostocalcium

The storage of Ostocalcium, which contains a calcium salt and Colecalciferol (Vitamin D3), is strictly governed by regulatory requirements to maintain product stability.

Official Storage Requirements

The product must be stored at a temperature not exceeding 30°C. It must be protected from direct sunlight and moisture. The Oral Suspension form carries the specific instruction: Do not freeze. The suspension should also be kept in a well-closed container. A mandatory safety rule requires that both the tablets and suspension be kept out of reach of children.

Disposal Instructions

Official labeling does not provide product-specific disposal instructions for unused or expired Ostocalcium. Disposal should follow general regulatory guidelines for discarding medicines in household trash, as advised by national health authorities for non-hazardous products.